AbbVie's Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Including Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Including Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Including Stroke Today - Breaking & Trending Today
Investegate |Indivior PLC Announcements | Indivior PLC: 3rd Quarter Results
Investegate announcements from Indivior PLC, 3rd Quarter Results
Source: investegate.co.uk
Alkermes Announces FDA Approval of LYBALVI for the Treatment of Schizophrenia and Bipolar I Disorder
-- New Oral Medication Offers Established Antipsychotic Efficacy of Olanzapine With Less Weight Gain -- -- Commercial Launch Planned for Fourth Quarter 2021 -- -- Company to Host Investor
Source: finanznachrichten.de
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVI™ (olanzapine and samidorphan)...
Source: prnewswire.co.uk
CSRWire - Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented Published 05-04-21 Submitted by Alkermes DUBLIN, May 4, 2021 /CSRwire/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include: American Psychiatric Association (APA) Annual Meet...
Source: csrwire.com